Supermax Corporation

Equities

SUPERMX

MYL7106OO007

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA Other stock markets 06:00:00 2024-04-22 pm EDT			5-day change	1st Jan Change
0.825 ^MYR	+3.12%		+1.85%	-12.23%

Feb. 20	Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Supermax Names CEO, COO	MT

Tranche Update on Supermax Corporation Berhad's Equity Buyback Plan announced on January 22, 2021.

August 26, 2021 at 08:34 am EDT

From April 1, 2021 to June 30, 2021, the company has repurchased 0 shares, representing 0% for MYR 0 million. With this, the company has completed the repurchase of 8,151,600 shares, representing 0.32% for MYR 43.23 million under the buyback announced on January 22, 2021.

Latest news about Supermax Corporation

Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 20	CI
Supermax Names CEO, COO	Dec. 20	MT
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024	Dec. 19	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024	Dec. 19	CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok, as Independent and Non Executive Member of Risk Committee, Effective 02 Jan 2024	Dec. 19	CI
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Re-Designation of Tan Chee Keong as Senior Executive Director from Executive Director. Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Gan Kim Khoon as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Wong Phait Lee as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Resignation of Puan Rozita Binti Abdul Rahman as Independent and Non Executive Member of Audit Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Gan Kim Khoon as Independent and Non Executive Member of Audit Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Wong Phait Lee as Independent and Non Executive Member of Audit Committee, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Announces Re-Designation of Tan Chee Keong as Chief Executive Officer from Executive Director, Effective January 2, 2024	Dec. 18	CI
Supermax Corporation Berhad Appoints Mr. Yip Kit Weng as Independent and Non Executive Member of Risk Committee, Effective on January 02, 2024	Dec. 18	CI
Supermax Corporation Bhd Appoints Tan Chee Keong or CK Tan as its Senior Executive Director Effective January 2, 2024	Dec. 17	CI
Supermax Corporation Bhd Appoints Tan Chee Keong or CK Tan as Chief Executive Officer, Effective January 2, 2024	Dec. 17	CI
Supermax's First Manufacturing Facility in Texas Nears Completion	Dec. 10	MT
Supermax Corporation Berhad Announces Cessation of Miss Tan Poh Chan as Independent and Non Executive Chairman of Risk Committee	Dec. 08	CI
Supermax Corporation Berhad Announces Retirement of Miss TAN POH CHAN as Independent and Non Executive Director	Dec. 08	CI
Supermax Corporation Berhad Announces Cessation of Miss TAN POH CHAN as Independent and Non Executive and Member of Audit Committee	Dec. 08	CI
Supermax Corporation Berhad Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 29	CI
Glass Lewis ESG Controversy Alert: Supermax	Nov. 22	MT

Chart Supermax Corporation

Duration

Period

More charts

Company Profile

Supermax Corporation Berhad is an investment holding company, engaged in the production of rubber gloves. The Company operates through four segments: Investment holding, Manufacturing of gloves, Trading of gloves and Others. The Company is an international manufacturer, distributor, and marketer of medical gloves. It manufactures various types of nitrile latex and natural rubber gloves, which are exported to over 165 countries around the world, such as the United States of America, European Union, Middle East, Asia, and South Pacific countries. The Company owns a range of brands, such as Supermax, Aurelia and Maxter, which are used by laboratories, hospitals, pharmacists, doctors, and surgeons throughout the world. It produces over 26 billion pieces of gloves per year. It has approximately eight distribution centres based in the United States of America, Brazil, Canada, Germany, Hong Kong, and United Kingdom.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-14 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Supermax Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.825 MYR

Average target price

0.9633 MYR

Spread / Average Target

+16.77%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
SUPERMAX CORPORATION	-12.23%	431M
COLOPLAST A/S	+18.73%	28.89B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-34.56%	2.83B
WINNER MEDICAL CO., LTD.	-8.99%	2.7B
INTCO MEDICAL TECHNOLOGY CO., LTD.	-2.44%	2.01B
HARTALEGA HOLDINGS	-0.74%	1.88B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-11.44%	1.79B
TOP GLOVE CORPORATION BHD.	-6.11%	1.37B
KOSSAN RUBBER INDUSTRIES	+14.59%	1.13B
KANGJI MEDICAL HOLDINGS LIMITED	+3.58%	1.06B

Medical Supplies